Experience of Using Scenar Therapy in Treating Some Neurological Pain Syndromes by T. Volyanik

SCENAR is an effective device for the treatment of many diseases. This effectiveness is provided by the main specificity of SCENAR action.

High-amplitude (but non-damaging) action;
Absence (substantial diminishing) of the process of adaptation. Due to return biological connection, each impulse is different from the previous. As a result, SCENAR action activates considerable amounts of neuro-fibres, including thin C-fibres, which makes this treatment different from other types of electrotherapy.
Chemical intermediates (neuro-mediators) in these fibres are made from numerous groups of neuro-peptides, which, when combined with other humor factors, provide any possible biologic function.

The anti-pain effect from SCENAR comes about because of stimulation of the production of not only endorphins, but also other neuro-peptides (neuro-tensine, cholecysto-kinin, etc.) which regulate nociceptive and anti-nociceptive endogenous systems.

Anti-pain effects from SCENAR action was used for treating patients with Neuralgia of the Trigeminal Nerve (NTN) and with Herpes Zoster.

During 1,5 years 6 patients with NTN were treated, 5 men and one women, aged 48 -70. Duration of the disease was from 1,5 -5 years. Most of the patients had their sessions daily. After 10 sessions one patient had a full remission, without taking finlipsine, for 6 months, another had a remission on the background of low dosages of finlipsine. One patient did not have a complete remission. For two patients the treatment was not effective (one of them received only 5 sessions). There were no neuralgic foci symptoms on examination of the patients. Two patients had CT of the brain (normal according to their age).

There were 13 patients with Herpes Zoster in the second group. Time of the action was 10 - 15 minutes before pain disappeared. Most of the patients had the session's daily, some of them two times a day.

There were 12 patients with an acute stage of Herpes Zoster, - 5 males, 7 females - aged from 31 to 70 years. 5 patients had herpes rash at the zone of enervation of the trigeminal nerve, 5 on the level of thoracic segments, 2 on the level of lumbar segments. 8 out of 12 were using limited drug therapy. Analgesic effect was observed straight away after the first SCENAR action and lasted for 5 -8 hours; the pain then resumed, but was less acute. After 3 -5 sessions, 8 patients experienced a complete cessation of pain, while the others had considerable improvement. Catamnesis (delayed results) are known for 8 patients from 3 months to 1,5 years - the pain syndrome did not resume.

Four women of ages 68 to 82 had treatment concerning Post Herpes neuralgia, which lasted from 1 to 2 years. Three patients suffered with pain at the level of thoracic segments. For this period of time, different types of physiotherapy were used without a considerable effect. After 10 sessions of SCENAR therapy, the pain had stopped completely and for 1 - 1,5 years did not resume.

One patient aged 82 suffered with acute and frequent pain around the chest at the level of thoracic segments for 1,5 years. During this period she received a few courses of IRT, different type of physiotherapy, and one course of roentgenotherapy, without any effect. The patient was given 3 courses of SCENAR therapy in combination with IRT for 10-16 sessions a course with a break for 3-4 weeks. To clarify the location of zones for the treatment, the reflexo-diagnostic set "RISTA -EPD" was used. The effect from the treatment was quick, mainly during the therapy. Catamnesis - pain was still there, but not as intensive.

SCENAR therapy provides, in the majority of cases, a quick, positive effect in the treatment of Herpes Zoster, especially in the acute stages. The therapy allows a considerable reduction in the intake of medicines, increases the defensive characteristics of the body and also helps the patients to get rid of pain in situations when other ways of treatment are less effective.